Alpha Teknova Inc
Research Alpha Teknova Inc (TKNO) on Bullrun: market cap USD 303.99M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerTKNO
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 303.99M
- Financial periodFY2025
- RevenueUSD 40.52M
- Revenue growth7.4%
- Net income-USD 17.26M
- Free cash flow-USD 9.79M
- Gross margin33.2%
Valuation Snapshot
latest market cap is USD 303.99M.
About Alpha Teknova Inc
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.
Frequently asked questions
What is Alpha Teknova Inc's market cap?
Alpha Teknova Inc's market capitalization is USD 303.99M.
What does Alpha Teknova Inc do?
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning;